GRS

TRANSLATE

MENU menu

Close close menu

GRS Blog

PAST POSTS menu

Close close menu

Europe: Medical Devices - The Notified Body Consultation Procedure, Part 2

27/9/2011

Manufacturers of medical devices incorporating ancillary substances should have a clear understanding of the consultation procedure that their Notified Body will have to follow.

 

Part 1 discussed the regulatory requirements and important guidance documents.

 

Part 2 covers aspects of the process itself, required documentation and fees.  More...

 

Author: Greer Deal, Director of Global Regulatory Services (GRS)

Past Posts...

Stem Cells and Autism
18 September 2011